Navigation Links
ClinOps Announces Appointment of New President and CEO
Date:10/25/2010

SAN FRANCISCO, Oct. 25 /PRNewswire/ -- ClinOps, LLC (formerly Pacific Data Designs) today announced that David Herron has been appointed to the organization as president and chief executive officer.  In addition, David has been named to ClinOps' Board of Directors.  

"David is well equipped to lead this company into the next phase of its maturity.  His global sales experience, business relationships and operational leadership are fundamentally important to ClinOps growth over the next five years.  David brings tremendous knowledge of professional and technical healthcare services with extensive emphasis on clients, quality and operations," said ClinOps Chairman, Rod Boone.  "David is a proven executive, focused on driving business results."

Prior to joining ClinOps, Mr. Herron held a number of leadership positions at SYNARC, the world's largest central imaging lab, most recently as Chief Operating Officer.  Mr. Herron has also held senior management positions at Webify Solutions (acquired by IBM), Vitria Technology and Health Net.  He is a seventeen-year veteran of the US military serving in the US Marine Corps and as an Adjutant General and Logistics Officer.  He was thrice decorated during Operations Desert Shield & Storm.  He is a distinguished graduate of Lipscomb and Vanderbilt universities.

The ClinOps Board of Directors is confident the combination of David's experience and passion will lead to continued growth and superior services for ClinOps customers.

About ClinOpsClinOps, LLC is a streamlined contract research organization that focuses on understanding and fulfilling each customer's needs and delivering top-quality results within aggressive timelines.  We specialize in four critical service areas: Clinical Operations, Data Management, Biostatistics and Data Rescue Services at www.clinops.com.Media Contact:Natalie Cummins908 209 7726
'/>"/>

SOURCE ClinOps, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Announces Q310 Earnings Conference Call
2. NYSCF announces 2010 NYSCF Investigators
3. Onconova announces FDA agreement of a SPA for a pivotal phase 3 trial of Estybon in MDS
4. Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards
5. TERMIS-North America announces speakers for annual event
6. American Society of Agronomy announces the class of 2010 Fellows
7. American Society of Agronomy announces award recipients
8. Biophysical Society announces 2011 society fellows
9. ActiveCare, Inc. Announces Capital Raise Commitment and Balance Sheet Restructuring
10. BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule
11. The American Ceramic Society announces 2010 Distinguished Life Members and class of Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 ... genomic services and solutions with cutting edge next-generation sequencing ... completed a USD $75 Million [515 Million RMB] B ... International Capital Management ( Shenzhen ) Co., ... ("SDIC Innovation") and Shanghai Sigma Square Investment Center LP ...
(Date:11/30/2016)... -- Part of 5m$ Investment in Integrated Drug ... , ... today announced that it had successfully completed the expansion of ... increased the Screening Collection to over 400,000. The new compounds ... the company. This expansion, complemented by new robotics and compound ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule cocrystal ... the latest FDA guidance on pharmaceutical cocrystals as drug substance . The ... , The event follows the successful November 15th event that took place in ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... of a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s ...
Breaking Biology Technology: